Medical Devices Seed Investors & VC Firms

1155 firms in this list, with a median first check of $500K. 233 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
OR Originate Ventures EAGRMGE6 people	88🔒	Bethlehem	US	Seed–Series A	$500K – $4M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLCW12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM
ID IDG Capital JNMLQZXL5 people	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	$3M – $200M	+ Add to CRM
NY NYBC Ventures CDJMMWCC8 people · Follows rounds	88🔒	—		Seed–Series B	—	+ Add to CRM
OX Oxford Investment Consultants LLP GRPLRHCH11 people	88🔒	Oxford	GB	Seed–Late Stage	—	+ Add to CRM
SN Snatched Ventures AKKCAZ4 people · Follows rounds	88🔒	San Francisco	US	Pre-Seed–Series A	—	+ Add to CRM
CA Cancer Fund ALABJRAD9 people	88🔒	Phoenix	US	Seed–Series C	—	+ Add to CRM
NE Newpath Partners DYTCTT3 people · Follows rounds	88🔒	Boston	US	Seed–Series A	$50K – $10M	+ Add to CRM
BR Brown and White Ventures CTJACDDD7 people	88🔒	Fairport	US	Pre-Seed–Seed	—	+ Add to CRM
PA Pandect Bioventures MXMTWHRW10 people	88🔒	Woodside	US	Seed–Late Stage	—	+ Add to CRM
SH Shoni Health Ventures DRELSGBG9 people	88🔒	Ramat Gan	IL	Pre-Seed–Growth	—	+ Add to CRM
TU TusStar	88🔒	Beijing	CN	Pre-Seed–Growth	—	+ Add to CRM
YZ YZR Capital MFPDDMHE6 people · Leads rounds	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
BI BioCrossroads VWMBEASG11 people	88🔒	Indianapolis	US	Seed	—	+ Add to CRM
IN Incentive, Peregrine Ventures Incubator BLELLSD(11 people	88🔒	Israel	IL	Pre-Seed–Growth	—	+ Add to CRM
OC OCV Partners RRALCBHZ5 people · Leads rounds	88🔒	Los Angeles	US	Pre-Seed–Late Stage	—	+ Add to CRM
VE Vesalius Biocapital Partners APCSGMSV5 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M	+ Add to CRM
TO Torrey Pines Investment NSCRERMP7 people · Leads rounds	88🔒	San Diego	US	Seed–Series A	—	+ Add to CRM
ET ETCapital MRJGDG3 people · Follows rounds	88🔒	Cambridge	GB	Pre-Seed–Series A	$100K – $952.5K	+ Add to CRM
HE Healthier Capital ADAMEEGK6 people	88🔒	Menlo Park	US	Seed–Series B	—	+ Add to CRM
LU Lucas Venture Group JBSLCCLW6 people	88🔒	Palo Alto	US	Pre-Seed–Series A	$1M – $5M	+ Add to CRM
PU Pulse Angels AMMS6 people	88🔒	—	GB	Pre-Seed–Seed	$65K – $650K	+ Add to CRM
SH Shenzhen Capital Group DZSLXW3 people	88🔒	Shenzhen	CN	Seed–Growth	$1.5M – $156M	+ Add to CRM
ES Esplanade Ventures SESMESAN11 people · Leads rounds	88🔒	Toronto	CA	Pre-Seed–Series B	—	+ Add to CRM

Originate Ventures

BethlehemSeed–Series A$500K – $4M

EAGRMGE6 people

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLCW12 people

IDG Capital

Hong KongPre-Seed–Late Stage$3M – $200M

JNMLQZXL5 people

NYBC Ventures

Seed–Series B

CDJMMWCC8 people

Oxford Investment Consultants LLP

OxfordSeed–Late Stage

GRPLRHCH11 people

Snatched Ventures

San FranciscoPre-Seed–Series A

AKKCAZ4 people

Cancer Fund

PhoenixSeed–Series C

ALABJRAD9 people

Newpath Partners

BostonSeed–Series A$50K – $10M

DYTCTT3 people

Brown and White Ventures

FairportPre-Seed–Seed

CTJACDDD7 people

Pandect Bioventures

WoodsideSeed–Late Stage

MXMTWHRW10 people

Shoni Health Ventures

Ramat GanPre-Seed–Growth

DRELSGBG9 people

TusStar

BeijingPre-Seed–Growth

YZR Capital

MunichPre-Seed–Growth

MFPDDMHE6 people

BioCrossroads

IndianapolisSeed

VWMBEASG11 people

Incentive, Peregrine Ventures Incubator

IsraelPre-Seed–Growth

BLELLSD(11 people

OCV Partners

Los AngelesPre-Seed–Late Stage

RRALCBHZ5 people

Vesalius Biocapital Partners

LuxembourgSeed–Late Stage$11M

APCSGMSV5 people

Torrey Pines Investment

San DiegoSeed–Series A

NSCRERMP7 people

ETCapital

CambridgePre-Seed–Series A$100K – $952.5K

MRJGDG3 people

Healthier Capital

Menlo ParkSeed–Series B

ADAMEEGK6 people

Lucas Venture Group

Palo AltoPre-Seed–Series A$1M – $5M

JBSLCCLW6 people

Pulse Angels

Pre-Seed–Seed$65K – $650K

AMMS6 people

Shenzhen Capital Group

ShenzhenSeed–Growth$1.5M – $156M

DZSLXW3 people

Esplanade Ventures

TorontoPre-Seed–Series B

SESMESAN11 people

Data sourced from public filings and firms' own websites — see our methodology.